Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
NeuroVive Pharmaceutical AB Year End Report January - December 2019
2020-02-19 16:08
NeuroVive Announces Settlement in Dispute With CicloMulsion AG
2019-12-16 18:33
NeuroVive Pharmaceutical AB Interim Report January - September 2019
2019-11-20 16:38
NeuroVive Pharmaceutical AB Interim Report January - June 2019
2019-08-21 15:24
NeuroVive's IND for Clinical Development of NeuroSTAT Approved by FDA
2019-05-10 15:05
NeuroVive Pharmaceutical AB Publishes 2018 Annual Report
2019-03-25 17:58
NeuroVive Receives Vinnova Funding to Support Development of NV354, a Novel Treatment for Genetic Mitochondrial Disorders
2018-11-15 19:37
NeuroVive Reports First NeuroSTAT Clinical Efficacy Signal in TBI
2018-10-04 15:43
NeuroVive Receives Positive FDA Feedback on its NeuroSTAT TBI Development Plan
2018-09-06 15:10
NeuroVive's NVP015 Program Will be Accelerated Through Award of Major Research Grant to Children's Hospital of Philadelphia
2018-08-28 15:21
NeuroVive Pharmaceutical AB Interim Report January - June 2018
2018-08-21 15:22
NeuroVive Out-licenses Targeted LHON Therapy to BridgeBio Pharma's New Subsidiary Fortify Therapeutics
2018-06-19 04:39
NeuroVive Pharmaceutical AB Interim Report January - March 2018
2018-05-22 15:22
NeuroVive Initiates Collaboration With Leading US TBI Research Organization
2018-05-02 15:24
Amendment: Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ)
2018-04-27 20:38
NeuroVive Presents NVP025 Mitochondrial Myopathy Project Progress at Mitochondrial Medicine Conference
2018-04-20 18:52
NeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment
2018-04-17 15:03
NeuroVive Decides on a Rights Issue for Continued Drug Development
2018-02-15 16:18
NeuroVive Reports Breakthrough in Mitochondrial Myopathy Project
2018-01-29 21:05
NeuroVive to Present at the 10th Annual Biotech Showcase Conference
2018-01-03 16:10
1